PROTECTING PUBLIC FROM TERATOGENIC AND MUTAGENIC HAZARDS

被引：19

作者：

BRENT, RL

机构：

来源：

JOURNAL OF CLINICAL PHARMACOLOGY AND NEW DRUGS | 1972年 / 12卷 / 2-3期

关键词：

D O I：

10.1002/j.1552-4604.1972.tb00147.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：61 / &

共 21 条

[1]

BAKER JBE, 1967, PHARMAZEUTISCHE IND, V29, P759

BRENT, RL .

[3]

BRENT RL, 1961, P SOC EXP BIOL MED, V106, P523, DOI 10.3181/00379727-106-26390

BRENT, RL ;

JOHNSON, AJ ;

JENSEN, M .

[5] MEDICOLEGAL ASPECTS OF TERATOLOGY [J].

BRENT, RL .

[6]

BRENT RL, 1971, APR COMM EX REORG GO, P165

[7]

BRENT RL, 1971, APR COMM EX REORG GO, P76

[8]

BRENT RL, 1969, 204 EXC MED INT C SE, P187

[9]

BRENT RL, 1971, ADV BIOSCIENCE, V6, P421

[10]

CAHEN RL, 1964, CLIN PHARMACOL THER, V5, P480